President Trump signed an executive order yesterday to lower prescription drug prices by “putting America first,” but experts are unsure if this move will have a direct impact on rising...
Patients with deductibles and coinsurance for brand medicines have significantly higher annual out-of-pocket costs than patients with fixed copays alone, according to a new analysis.
The analysis...
Department of Justice (DOJ) recently charged Glenmark Pharmaceuticals Inc. for the it role in antitrust violations from May 2013 to December 2015.
The DOJ’s complaint alleged that the...
US taxpayers and the healthcare sector may save nearly $7 billion annually with a stronger, more competitive biosimilars market, which is a significant increase from the current annual cost-savings of...
Two-thirds of US adults reported that prescription drug prices have increased either “a little” or “a lot” since 2017, the first year of the Trump administration, according to a...
A district court in New York recently announced that a major opioid trial slated to take place next week will be delayed due to COVID-19 concerns.
The trial against multiple opioid manufacturers...
Manufacturers increased prescription drug prices for four drugs commonly used by hospitals after receiving FDA approval, creating an estimated $20.25 billion in additional healthcare spending over...
The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...
Tying drug prices to those in other developed countries may be a useful strategy for lowering US prescription drug spending, but international reference pricing may not be ideal, according to...
The FDA announced that Operation Broadsword, its enforcement operation with the Government of India, stopped nearly 500 shipments of illicit prescription drugs and medical devices from reaching...
Prescription drug prices continue to increase due to continued growth in medical service costs and a modest uptick in utilization, according to a recent report from the Health Care Cost Institute...
The city of Marietta has filed a class action lawsuit against drug manufacturer Mallinckrodt, claiming the company increased the price for a specific seizure medication by 97,500 percent, according to...
According to a GoodRx analysis, Myalept is the most expensive prescription drug in the US in 2020 with a list price of $72,306.
In their yearly analysis, GoodRx researchers broke down the most...
A coalition of more than 40 conservative groups led by Americans for Tax Reform urged the administration to withdraw its International Pricing Index (IPI) proposal for Medicare Part B drugs.
CMS...
Drug prices increased for 686 drug products during the first few weeks of 2020, the latest data from the Centers for Medicare and Medicaid Services shows, signaling it’s business as usual for...
Nearly a quarter of a million providers are using a point-of-care drug price transparency tool and benefits checker when prescribing patients a medication, a considerable step up in recent years,...
The pharmaceutical industry could lose $1 trillion in overall revenue and still remain as one of the most lucrative industries in the country, according to research conducted in partnership between...
Industry experts have come to agree that the traditional method for financing the healthcare system is not working. National healthcare expenditures are accelerating at an unsustainable rate, with...
